Literature DB >> 6018911

Eye and skin changes in psychiatric patients treated with chlorpromazine.

M B Mathalone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6018911      PMCID： PMC506336          DOI： 10.1136/bjo.51.2.86

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  18 in total

1.  DERMATOLOGICAL AND OPHTHALMOLOGICAL CHANGES ASSOCIATED WITH PROLONGED CHLORPROMAZINE THERAPY.

Authors:  P E FELDMAN; B D FRIERSON
Journal:  Am J Psychiatry       Date:  1964-08       Impact factor: 18.112

2.  OPHTHALMOLOGIC FINDINGS IN PATIENTS ON LONG-TERM CHLORPROMAZINE THERAPY.

Authors:  R BOCK; J SWAIN
Journal:  Am J Ophthalmol       Date:  1963-11       Impact factor: 5.258

3.  SKIN PIGMENTATION, A RARE SIDE EFFECT OF CHLORPROMAZINE.

Authors:  T A BAN; H E LEHMANN
Journal:  Can Psychiatr Assoc J       Date:  1965-04

4.  OCULAR CHANGES ASSOCIATED WITH LONG-TERM CHLORPROMAZINE THERAPY.

Authors:  S L DELONG; B J POLEY; J R MCFARLANE
Journal:  Arch Ophthalmol       Date:  1965-05

5.  LENTICULAR AND CORNEAL OPACITIES DURING PHENOTHIAZINE THERAPY.

Authors:  J A BARSA; J C NEWTON; J C SAUNDERS
Journal:  JAMA       Date:  1965-07-05       Impact factor: 56.272

6.  A NEW AND UNUSUAL REACTION TO CHLORPROMAZINE.

Authors:  A S ZELICKSON; H C ZELLER
Journal:  JAMA       Date:  1964-04-27       Impact factor: 56.272

7.  The concentration of phenothiazines in the eye of experimental animals.

Authors:  A M POTTS
Journal:  Invest Ophthalmol       Date:  1962-08

8.  The ocular toxic findings with prolonged and high dosage chlorpromazine intake.

Authors:  J R Siddall
Journal:  Arch Ophthalmol       Date:  1965-10

9.  SKIN PIGMENTATION AND CORNEAL AND LENS OPACITIES WITH PROLONGED CHLORPROMAZINE THERAPY.

Authors:  A C GREINER; K BERRY
Journal:  Can Med Assoc J       Date:  1964-03-14       Impact factor: 8.262

10.  THERAPY OF CHLORPROMAZINE MELANOSIS: A PRELIMINARY REPORT.

Authors:  A C GREINER; G A NICOLSON; R A BAKER
Journal:  Can Med Assoc J       Date:  1964-09-19       Impact factor: 8.262
View more
  6 in total

Review 1.  Ocular adverse effects of neuropsychiatric agents. Incidence and management.

Authors:  T Oshika
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606

2.  Ocular effects of chlorpromazine and oxypertine on beagle dogs.

Authors:  J Legros; I Rosner; C Berger
Journal:  Br J Ophthalmol       Date:  1971-06       Impact factor: 4.638

3.  Toxic effects of phenothiazines on the eye.

Authors:  D J Boet
Journal:  Doc Ophthalmol       Date:  1970-07-24       Impact factor: 2.379

4.  Optic atrophy during chlorpromazine therapy.

Authors:  S M Rab; M N Alam; M D Sadequzzaman
Journal:  Br J Ophthalmol       Date:  1969-03       Impact factor: 4.638

5.  Ocular changes resulting from therapy with amiodarone.

Authors:  D V Ingram; N S Jaggarao; D A Chamberlain
Journal:  Br J Ophthalmol       Date:  1982-10       Impact factor: 4.638

6.  Pathogenesis of degenerative retinopathies induced by thioridazine and other antipsychotics: a dopamine hypothesis.

Authors:  Pantaleo Fornaro; Giovanni Calabria; Guido Corallo; Giovanni B Picotti
Journal:  Doc Ophthalmol       Date:  2002-07       Impact factor: 2.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.